BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1677 related articles for article (PubMed ID: 18555777)

  • 1. Chemokine signaling via the CXCR2 receptor reinforces senescence.
    Acosta JC; O'Loghlen A; Banito A; Guijarro MV; Augert A; Raguz S; Fumagalli M; Da Costa M; Brown C; Popov N; Takatsu Y; Melamed J; d'Adda di Fagagna F; Bernard D; Hernando E; Gil J
    Cell; 2008 Jun; 133(6):1006-18. PubMed ID: 18555777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
    Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
    Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor CXCR2 is transactivated by p53 and induces p38-mediated cellular senescence in response to DNA damage.
    Guo H; Liu Z; Xu B; Hu H; Wei Z; Liu Q; Zhang X; Ding X; Wang Y; Zhao M; Gong Y; Shao C
    Aging Cell; 2013 Dec; 12(6):1110-21. PubMed ID: 23869868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for CXCR2 in senescence, but what about in cancer?
    Acosta JC; Gil J
    Cancer Res; 2009 Mar; 69(6):2167-70. PubMed ID: 19276354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic NF-kappaB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response.
    Batsi C; Markopoulou S; Vartholomatos G; Georgiou I; Kanavaros P; Gorgoulis VG; Marcu KB; Kolettas E
    Mech Ageing Dev; 2009 Jul; 130(7):409-19. PubMed ID: 19406145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.
    Vizioli MG; Santos J; Pilotti S; Mazzoni M; Anania MC; Miranda C; Pagliardini S; Pierotti MA; Gil J; Greco A
    Oncotarget; 2014 Sep; 5(18):8270-83. PubMed ID: 25268744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
    Dong YL; Kabir SM; Lee ES; Son DS
    PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network.
    Orjalo AV; Bhaumik D; Gengler BK; Scott GK; Campisi J
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17031-6. PubMed ID: 19805069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras.
    Wislez M; Fujimoto N; Izzo JG; Hanna AE; Cody DD; Langley RR; Tang H; Burdick MD; Sato M; Minna JD; Mao L; Wistuba I; Strieter RM; Kurie JM
    Cancer Res; 2006 Apr; 66(8):4198-207. PubMed ID: 16618742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis.
    Lesina M; Wörmann SM; Morton J; Diakopoulos KN; Korneeva O; Wimmer M; Einwächter H; Sperveslage J; Demir IE; Kehl T; Saur D; Sipos B; Heikenwälder M; Steiner JM; Wang TC; Sansom OJ; Schmid RM; Algül H
    J Clin Invest; 2016 Aug; 126(8):2919-32. PubMed ID: 27454298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway.
    Chandrasekar B; Melby PC; Sarau HM; Raveendran M; Perla RP; Marelli-Berg FM; Dulin NO; Singh IS
    J Biol Chem; 2003 Feb; 278(7):4675-86. PubMed ID: 12468547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells.
    Li B; Hou D; Guo H; Zhou H; Zhang S; Xu X; Liu Q; Zhang X; Zou Y; Gong Y; Shao C
    Sci Rep; 2017 Mar; 7(1):208. PubMed ID: 28303009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of senescence by CXCR2 and its ligands.
    Acosta JC; O'Loghlen A; Banito A; Raguz S; Gil J
    Cell Cycle; 2008 Oct; 7(19):2956-9. PubMed ID: 18838863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The M-type receptor PLA2R regulates senescence through the p53 pathway.
    Augert A; Payré C; de Launoit Y; Gil J; Lambeau G; Bernard D
    EMBO Rep; 2009 Mar; 10(3):271-7. PubMed ID: 19197340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-Bound CD40L Promotes Senescence and Initiates Senescence-Associated Secretory Phenotype via NF-κB Activation in Lung Adenocarcinoma.
    Xu W; Li Y; Yuan WW; Yin Y; Song WW; Wang Y; Huang QQ; Zhao WH; Wu JQ
    Cell Physiol Biochem; 2018; 48(4):1793-1803. PubMed ID: 30078020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of senescence and the SASP by the transcription factor C/EBPβ.
    Salotti J; Johnson PF
    Exp Gerontol; 2019 Dec; 128():110752. PubMed ID: 31648009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.
    Ignacio RM; Kabir SM; Lee ES; Adunyah SE; Son DS
    PLoS One; 2016; 11(10):e0164189. PubMed ID: 27723802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists.
    Erin N; Nizam E; Tanrıöver G; Köksoy S
    Breast Cancer Res Treat; 2015 Feb; 150(1):57-69. PubMed ID: 25682075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
    Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
    Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR1/2 Chemokine Network Regulates Melanoma Resistance to Chemotherapies Mediated by NF-κB.
    Wu S; Saxena S; Varney ML; Singh RK
    Curr Mol Med; 2017; 17(6):436-449. PubMed ID: 29256349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.